Document pmQLMpJXozQ8bDBE4YbyM4apB

ST internal Comespondence +7AR226-048H eakts Eval. D. th. Duoeak = Spec. Chem. - 41-1 Fam L. 2obel M.D. Medical - 220-25-02 Siomct Hodical Examinations 3N = ove March 20, 1987 nnn,, oExraimoirneastsionositowreerde thdeonee ponr6o4%m (204/32302)0),of the Specialty Chemical Ainfitrhset clreovewl aosf +anawlhyoslei.s ofItnhvisicdattaa sshiowns pnooresiiigfinciafnitcanptropbrolbelensss abnormalities have already been referred to personal physicians. JadHaeeanpreegernicadnliianlcgreenatobennrtohohanr.ocwmeaSntplohoirpmtuaaiiinlaedtnsliio3nml5tia%tbspteaerrseetesndteoifciicenuerdo.fwitthNhoeramnaealesxtipsecvteoerfdoteennfrdeSeqofurieinnneceddy MtEIehnu'enccteeshlpeolanrraeSTnpose5stcteiyaialvntiedysrF2C1ahleahmnnaiccraaeltcssCeSraearoscseitwrnegis.So1uS7MhoToohosaaednaTetaasatrpnolnereaemSsktaeoroionnEneeeoheiiheicgdhph baeLlniisvvstee:.r oKfKriuigdntancnnetesyiyonmffeuutnTnaeccsbtttoii,looinnzael"ttmeehossosttsts.t settxeoa`xcTeitmnnlaeystp.ae5cnCptileoeorfsienmlghyeestehoretmeimhmaeesoedtrnmLiyehtb,ioausMeby iotL,hoeesieSesae0tnyoe CEE to show subclinical ear aLTsihbnreiensegtonseowfextpa`toshsee.usrel.oufng:pIlteurfPaollretuutrnhaailtcekletynhiinc1gtemwmieanrrgeafmoSnupnidog.memseTTrheaCplserusraoiies Othtfhee taGufhsoarebetesesh.ese)trnoiosntadirIvestiiilndgadduntioaeceldoassftcecnaoeonnxtcatpne"iorrns.euuisernueclhtrteoeianGipsnaoetcdhedreioicusSisaidpeboiadiksttleaiionttftyfoonopGeraossrvteceillnio(cnmuiisoiceuasoallsLleYyssSyeEm2eap0nOstaoymNeessla.:?rls loIIttr 03590 E E et March 20, 1987 We plan to do more specific and detailed studies of the relationship of blood fluorine levels (current and past) and examination results. BSrpeevdmecegpfinny othee hprtocees wofeS0htnheeiriensgtserdpranetspriateacteosl.iTatiocnmin , We are in the process of obtaining appropriate consultation and 03591 ORGANIC FLUORIDE IN THE BLOOD SOURCES | FC-143, FC-126, FC-95, FC-98, FC-120 REMEDIES * ENGINEERING CONTROLS * PERSONAL PROTECTION EQUIPMENT * OPERATOR TRAINING/AWARENESS RESULTS FFRROOMM 319076PP~M19T8O4 1L0EPVPEML.S DECREAcSoEnoDr RFERMOAMIN19E8D4 C-OPNRSETSAENNTTOLREVIENLCSREHAASVEDE. CONCERNS EMPLOYEE HEALTH CORPORATE LIABILITY COMPLICATIONS ' 3-4 MONTH DELAY IN TEST RESULTS. INCREASE IN TEST REFUSAL. |ACK OF ENTHUSIASM FOR HEALTH SCREENING EXAMS. DIFFICULTY IN IMPLEMENTING COMPUTER CORRELATION PROGRAM. SOLUTIONS, GIVE EMPLOYEES A SMALL INCENTIVE FOR GIVING BLOOD SAMPLES TRANSPORT TO 3M CENTER/BUY LUNCH. SPEED UP TURNAROUND ON TEST. " SUPERVISOR INCENTIVES FOR REDUCING READINGS OF HIGH PERSONNEL. coassa Le HARFPLD . Boa 3 (<) usage S Block | LEVELS OF CONCERN 36 EMPLOYEES > 5 PPM 13 EMPLOYEES > 10 PPM PPM EMPLOYEES 31 19 18 14 13 2 1 10 2 2, () TERMINATED () OLD RESULTS NON-BUILDING 15 2 2 (2)NON-BUILDING 15 2 () SUPERVISOR FEMALE - 03594 ) BUILDING 15 | . FREE FLUORIDE LEVELS ET 30 K1000-------- - EX-K1000 -- Ki250 -- Qw 2 o0c I-) 20 w w Ts = a ER g& $ - a AUG `82 FEB'83 NOV `83 MAY `84 AUG '84 FEB'85 SEP `85 APR '86